These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31727077)

  • 21. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
    Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
    Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
    Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
    Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a panel of four microRNAs in CSF as a predicted biomarker for postoperative neoangiogenesis in moyamoya disease.
    Wang G; Wen Y; Chen S; Zhang G; Li M; Zhang S; Qi S; Feng W
    CNS Neurosci Ther; 2021 Aug; 27(8):908-918. PubMed ID: 33942536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated Analysis and Identification of CSF-Derived Risk miRNAs and Pivotal Genes in Multiple Sclerosis.
    Su Y; Li Z; Rang X; Wang Y; Fu J
    J Mol Neurosci; 2022 Sep; 72(9):1916-1928. PubMed ID: 35819635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.
    Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R
    JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
    Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
    Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.
    Müller M; Jäkel L; Bruinsma IB; Claassen JA; Kuiperij HB; Verbeek MM
    Mol Neurobiol; 2016 Jul; 53(5):2894-2899. PubMed ID: 25895659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics.
    Shi Y; Ding Y; Li G; Wang L; Osman RA; Sun J; Qian L; Zheng G; Zhang G
    Front Immunol; 2021; 12():700031. PubMed ID: 34489947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
    PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.
    Lusardi TA; Phillips JI; Wiedrick JT; Harrington CA; Lind B; Lapidus JA; Quinn JF; Saugstad JA
    J Alzheimers Dis; 2017; 55(3):1223-1233. PubMed ID: 27814298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
    Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
    Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
    Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
    Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
    Kiko T; Nakagawa K; Tsuduki T; Furukawa K; Arai H; Miyazawa T
    J Alzheimers Dis; 2014; 39(2):253-9. PubMed ID: 24157723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis.
    Li J; Wan Y; Guo Q; Zou L; Zhang J; Fang Y; Zhang J; Zhang J; Fu X; Liu H; Lu L; Wu Y
    Arthritis Res Ther; 2010; 12(3):R81. PubMed ID: 20459811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer.
    Juzėnas S; Saltenienė V; Kupcinskas J; Link A; Kiudelis G; Jonaitis L; Jarmalaite S; Kupcinskas L; Malfertheiner P; Skieceviciene J
    PLoS One; 2015; 10(7):e0132327. PubMed ID: 26172537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
    Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
    Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.